Among the different pro-inflammatory responses triggered by SARS-CoV-2 infection, IL-6 has been shown to be consistently elevated in the blood of severe COVID-19 patients [11,51,71] and can induce HSPCs [44] and human primary monocytes to develop into MDSC-like cells [72]. This evidence concerns the gene IL6 and COVID-19.